Jens D Lundgren
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort
Borges Á, Mulcahy F, Ridolfo A, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lundgren J, Mocroft A, Pradier C, Leen C, Pedersen C, Hoy J, Florence E, Sedlacek D, Stellbrink H, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort. Clin Infect Dis 2017; 64:1413-1421.
15.05.2017Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort
15.05.2017Clin Infect Dis 2017; 64:1413-1421
Borges Álvaro H, Mulcahy Fiona, Ridolfo Anna Lisa, Staub Therese, Maltez Fernando, Weber Rainer, Flamholc Leo, Kyselyova Galina, Lundgren Jens D, Mocroft Amanda, Pradier Christian, Leen Clifford, Pedersen Court, Hoy Jennifer, Florence Eric, Sedlacek Dalibor, Stellbrink Hans-Jürgen, Uzdaviniene Vilma, Tomazic Janez, Gargalianos-Kakolyris Panagiotis, Schmid Patrick, Orkin Chloe
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative
Rodger A, Lundgren J, Phillips A, Corbelli G, Van Lunzen J, Estrada V, Collins S, Vernazza P, Bruun T, PARTNER Study Group. Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative. Antivir Ther (Lond) 2013; 18:285-7.
24.04.2013Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative
24.04.2013Antivir Ther (Lond) 2013; 18:285-7
Rodger Alison J, Lundgren Jens D, Phillips Andrew N, Corbelli Giulio M, Van Lunzen Jan, Estrada Vicente, Collins Simon, Vernazza Pietro, Bruun Tina, PARTNER Study Group
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
Tillmann H, Lundgren J, Dragsted U, Hill A, Vernazza P, Monforte A, Antunes F, Staszewski S, Fox Z, Kaiser T, MaxCmin1 Trial Group. Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial. Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80.
01.11.2005Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
01.11.2005Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80
Tillmann Hans L, Lundgren Jens D, Dragsted Ulrik B, Hill Andrew, Vernazza Pietro, Monforte Antonella d'Arminio, Antunes Francesco, Staszewski Schlomo, Fox Zoe, Kaiser Thorsten, MaxCmin1 Trial Group
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Dragsted U, Lundgren J, Fox Z, Youle M, Vernazza P, Cassetti I, Hill A, Benetucci J, Bruun J, Clumeck N, Cahn P, Castagna A, Obel N, Duran A, Peters B, Pedersen C, Gerstoft J, MaxCmin1 Trial Group. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. The Journal of infectious diseases 2003; 188:635-42.
01.09.2003Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
01.09.2003The Journal of infectious diseases 2003; 188:635-42
Dragsted Ulrik Bak, Lundgren Jens D, Fox Zoe, Youle Mike, Vernazza Pietro, Cassetti Isabel, Hill Andrew, Benetucci Jorge, Bruun Johan N, Clumeck Nathan, Cahn Pedro, Castagna Antonella, Obel Niels, Duran Adriana, Peters Barry, Pedersen Court, Gerstoft Jan, MaxCmin1 Trial Group